SCHEMBL7399537

SCHEMBL7399537

O=C(CC1OCCc2cc(Br)ccc21)N1CCN(c2ccc(OCc3ccccc3)cc2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.48
NPSR1 Q6W5P4 2/20 0.48
DRD2 P14416 5/20 0.43
HTR1D P28221 5/20 0.43
HTR2A P28223 5/20 0.43
HTR1A P08908 3/20 0.43
DRD4 P21917 2/20 0.43
KDM4E B2RXH2 3/20 0.43
ME2 P23368 1/20 0.42
ME1 P48163 1/20 0.42
ME3 Q16798 1/20 0.42
GRIN1 Q05586 1/20 0.42
GRIN2B Q13224 1/20 0.42
HTR1B P28222 1/20 0.41
GPR183 P32249 1/20 0.41
MRGPRX4 Q96LA9 1/20 0.41
ALDH1A1 P00352 2/20 0.41
LMNA P02545 1/20 0.41
EPHX2 P34913 1/20 0.41
GRM5 P41594 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8591766 1.00 MAPT (0.48) MAPTNPSR1DRD2HTR1DHTR2A
SCHEMBL8592579 0.88 HTR1D (0.47) MAPTNPSR1DRD2HTR1DHTR2A
SCHEMBL8592577 0.88 HTR1D (0.47) MAPTNPSR1DRD2HTR1DHTR2A
SCHEMBL8593155 0.88 HTR1D (0.47) MAPTNPSR1DRD2HTR1DHTR2A
SCHEMBL7405316 0.86 ME2 (0.46) MAPTNPSR1DRD2HTR1DHTR2A
SCHEMBL8590591 0.86 DRD2 (0.57) MAPTDRD2HTR1DHTR2AHTR1A
SCHEMBL8590585 0.86 DRD2 (0.57) MAPTDRD2HTR1DHTR2AHTR1A
SCHEMBL8591792 0.86 DRD2 (0.57) MAPTDRD2HTR1DHTR2AHTR1A
SCHEMBL7398011 0.83 DRD2 (0.59) MAPTDRD2HTR1DHTR2AHTR1A
SCHEMBL8592428 0.83 DRD2 (0.59) MAPTDRD2HTR1DHTR2AHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6133446-A Heterocyclic compounds for the treatment of CNS and cardiovascular disorders PHARMACIA & UPJOHN COMPANY (US) 2000-10-17 US disclosed
EP-0737189-B1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS UPJOHN CO (US) 1999-07-28 EP disclosed
EP-0836599-A1 1,6-DISUBSTITUTED ISOCHROMANS FOR TREATMENT OF MIGRAINE HEADACHES PHARMACIA & UPJOHN COMPANY (US) 1998-04-22 EP disclosed
WO-1997002259-A1 1,6-DISUBSTITUTED ISOCHROMANS FOR TREATMENT OF MIGRAINE HEADACHES PHARMACIA & UPJOHN COMPANY (US) 1997-01-23 WO disclosed
EP-0737189-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS PHARMACIA & UPJOHN COMPANY (US) 1996-10-16 EP disclosed
WO-1995018118-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS THE UPJOHN COMPANY (US) 1995-07-06 WO disclosed